Location History:
- Rome, IT (2018)
- Civitavecchia, IT (2021)
Company Filing History:
2 out of 56 
1 out of 138 
1 out of 18 Years Active: 2018-2021
Title: Francesca Ghirga: Innovator in Cancer Treatment
Introduction
Francesca Ghirga is a prominent inventor based in Civitavecchia, Italy. She has made significant contributions to the field of cancer treatment, particularly in the development of innovative compounds aimed at combating T-cell acute lymphoblastic leukemia and other tumors.
Latest Patents
Francesca holds 2 patents that showcase her groundbreaking work. Her latest patents include "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia," which involves compounds with anti-tumor activity specifically targeting T-ALL. Another notable patent is "Multitarget hedgehog pathway inhibitors and uses thereof," which focuses on compounds that selectively inhibit the Hedgehog pathway, useful in treating Hh-dependent tumors like medulloblastoma.
Career Highlights
Throughout her career, Francesca has worked with esteemed institutions such as Università Degli Studi Di Roma "La Sapienza" and Fondazione Istituto Italiano Di Tecnologia. Her research has been pivotal in advancing therapeutic options for patients suffering from aggressive forms of cancer.
Collaborations
Francesca has collaborated with notable colleagues, including Bruno Botta and Cinzia Ingallina. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Francesca Ghirga's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations highlight her dedication to improving patient outcomes through scientific advancement.